An Insulin Sensitivity Study in Healthy Subjects

NCT02922426 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: ALKS 3831
DRUG: Olanzapine
DRUG: Placebo

Sponsor

Alkermes, Inc.